Skip to content

Effectiveness of Exercise and Patient-centred Education on Fibromyalgia

Is a Combined Programme of Exercise and Patient-centred Education More Effective Than Exercise Alone in Individuals With Fibromyalgia? A Randomised Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04220567
Enrollment
60
Registered
2020-01-07
Start date
2020-01-07
Completion date
2020-10-31
Last updated
2020-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Keywords

Fibromyalgia, Exercise, Patient-centred Education, Randomised Controlled Trial

Brief summary

This study aims to compare the effects of an eight-week exercise and patient-centred education programme with eight-week exercise alone programme on disability, pain intensity, health-related quality of life and patient global impression of change. A prospective, parallel, double-blinded and multi-centre randomised controlled trial will be carried out.

Interventions

OTHERExperimental: Exercise and Patient-centred education

An eight-week programme based on 24 sessions of exercise supervised by a physiotherapist. Exercise will be carried out three times a week. Once a week the exercise session is performed autonomously by patient at home (according to the physiotherapist's recommendations). Patient-centred Education will follow the principles of transformative learning & incorporate patients' narratives. It will precede 9 of the 24 exercise sessions and be delivered by the same physiotherapist

OTHERActive Comparator: Exercise

An eight-week programme based on 24 sessions of exercise supervised by a physiotherapist. Exercise will be carried out three times a week. Once a week the exercise session is performed autonomously by patient at home (according to the physiotherapist's recommendations).

Sponsors

Universidade de Lisboa - Faculdade Letras
CollaboratorUNKNOWN
Centro Hospitalar de Setúbal E.P.E.
CollaboratorUNKNOWN
Centro Hospitalar Lisboa Ocidental
CollaboratorOTHER_GOV
Myos - Associação Nacional Contra a Fibromialgia e Síndrome de Fadiga Crónica
CollaboratorUNKNOWN
Instituto Politécnico de Setúbal. Escola Superior de Saúde.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Double blind

Intervention model description

Parallel assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of fibromyalgia according to the American College of Rheumatology criteria (2016)

Exclusion criteria

* Presence of uncontrolled medical disorders (cardiovascular/ metabolic/ neurological/ renal) * Presence of active oncological disease (or until 5 years and undergoing treatment) * Presence of inflammatory rheumatic diseases other than fibromyalgia * Presence of inflammatory osteoarticular disease or severe osteoarthritis (grade IV de Kellgren - Lawrence Classification of Osteoarthritis) * Previous orthopaedic (column or lower limb) or cardiothoracic surgery in the year before; * Disability not compatible with the exercise practice required * Pregnancy * Attendance to a physiotherapy programme including exercise in the previous three months * Difficulty in written communication that prevent the fulfilment of self-reported questionnaires.

Design outcomes

Primary

MeasureTime frameDescription
Pain intensityBaselineMeasured using the Numeric Pain Rating Scale, NPS, 0-10
Disability and Impact of FibromyalgiaBaselineMeasured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100

Secondary

MeasureTime frameDescription
Neuropathic components in painBaselineMeasured using the painDETECT Questionnaire
Health-related Quality of LifeBaselineMeasured using the EuroQol 5D 3L, EQ 5D-3L
Patients' perception of improvement or decline in clinical status4 weeksMeasured using the The Patient Global Impression of Change Scale, PGIC, 1-7

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026